Heartland Group Holdings Limited Ordinary Shares
HGH.NZXFinancials
Heartland Group Holdings Limited (NZX:HGH) is a financial services group with operations in New Zealand and Australia. In New Zealand, Heartland Bank Limited (NZX:HBL) is a registered bank that focuses on 'best or only' banking products in three key markets: Household (which includes investment products, consumer lending, reverse mortgages and motor vehicle lending); Business; and Rural. In Australia, Heartland is a specialist provider of reverse mortgage loans and also provides funding to partners in the Small Business and Consumer Lending sectors. Since first listing on the NZX Main Board in February 2011, Heartland has successfully progressed through several strategic phases, establishing itself as a specialist financial services group that is listed on both the NZX Main Board and ASX under a Foreign Exempt Listing. A corporate restructure of the Heartland group was implemented in October 2018. For announcements prior to 1 November 2018 relating to Heartland shares, please refer to Heartland Bank Limited's listing (NZX:HBL).
Market Data
$1.140
+0.0%$1.1B
12.8x
$0.089
6.76%
+0.4%
Latest Earnings
Heartland announces 1H2026 result
26 February 2026
Heartland delivered a strong turnaround in 1H2026 with underlying NPAT of $46.1 million (up $35.4M vs prior period) and underlying ROE of 7.3%, driven by NIM expansion of 51 basis points to 3.92% and significant asset quality improvements. The company affirms FY2026 guidance of underlying ROE ≥7% and underlying NPAT ≥$85 million, with NSA realisation progressing ahead of expectations and tracking to be largely complete by June 2026. Key points: Strong turnaround with underlying ROE up 540 bps to 7.3%; Net interest margin expanded 51 bps to 3.92% driven by low cost of funds; Significant asset quality improvements with impairment expense ratio down 105 bps to 0.35%
Recent Announcements
Heartland trading update
Heartland Group Holdings Limited (NZX/ASX: HGH) provided a trading update for Q3 FY2026 (ended 31 March 2026), confirming it remains on track to deliver underlying ROE of at least 7% and underlying NPAT of at least $85 million for FY2026, with improvements in net interest margins, cost-to-income ratios, and asset quality across its New Zealand and Australian banking operations.
HGH 2026 Interim Dividend - ASX Appendix 2A
Heartland Group Holdings Limited is applying for quotation of 2,663,608 ordinary fully paid shares issued on March 20, 2026 under its Dividend Reinvestment Plan at an issue price of NZD 1.25186900 per share.
Notification of Allotment of Securities
Heartland Group Holdings Limited (HGH) allotted 2,663,608 fully paid ordinary shares at $1.251869 per share on 20 March 2026 to shareholders participating in the Dividend Reinvestment Plan, representing 0.28% of the total issued shares.
Heartland 2026 interim dividend: Updated ASX Appendix 3A.1
Heartland Group Holdings Limited updated its 2026 interim dividend notification, amending the strike price for its Dividend Reinvestment Plan (DRP). The interim dividend of NZD 0.04117647 per share (NZD 0.035 ordinary plus NZD 0.006176 supplementary) is payable on 20 March 2026 to shareholders on the record date of 6 March 2026, with DRP shares to be issued at NZD 1.25187.
HGH announces DRP strike price and AUD FX rate for dividend
Heartland Group Holdings Limited announces a DRP strike price of $1.25186934 per share for its dividend reinvestment plan, with shares issued instead of cash on 20 March 2026 based on the volume weighted average price over 5 trading days following the record date of 6 March 2026. The company also sets the AUD/NZD foreign exchange rate at 0.84145 for Australian dollar dividend payments.
ASX Appendix 3A.1
Heartland Group Holdings Limited (HGH) announced an ordinary dividend of NZD 0.04117647 per share (comprising NZD 0.035 ordinary + NZD 0.00617647 supplementary) for the six-month period ending 31/12/2025, payable on 20/3/2026 with an ex-date of 5/3/2026, and includes a dividend reinvestment plan (DRP) option with no discount available to eligible shareholders.
Heartland announces 1H2026 result
Heartland delivered a strong turnaround in 1H2026 with underlying NPAT of $46.1 million (up $35.4M vs prior period) and underlying ROE of 7.3%, driven by NIM expansion of 51 basis points to 3.92% and significant asset quality improvements. The company affirms FY2026 guidance of underlying ROE ≥7% and underlying NPAT ≥$85 million, with NSA realisation progressing ahead of expectations and tracking to be largely complete by June 2026. Key points: Strong turnaround with underlying ROE up 540 bps to 7.3%; Net interest margin expanded 51 bps to 3.92% driven by low cost of funds; Significant asset quality improvements with impairment expense ratio down 105 bps to 0.35%
Half year results announcement date
Heartland Group Holdings Limited (NZX/ASX: HGH) announced that it will release its half-year financial results for the period ended 31 December 2025 on Thursday 26 February 2026, with a live webcast for investors and analysts at 10:30am NZDT.
Get real-time alerts for HGH
Receive AI-powered earnings summaries and instant notifications when Heartland Group Holdings Limited Ordinary Shares releases results.
Register Free